Hématologie
PUBLICATIONS DANS DES REVUES INTERNATIONALES de LANGUE ANGLAISE
1 Circadian changes in anticoagulant effect of heparin infused at a constant rate.
JF Schved, JC Gris, JJ Eledjam.
British Medical Journal 1985, 290: 1286 (Letter).
2 Anti idiotypic antibodies against antiphospholipid autoantibodies which suppress lupus like anticoagulant activity.
JC Gris, JF Schved, D Tousch, S Hereil, O Feugeas.
Nouvelle Revue Françaised'Hématologie1988, 30: 143-147
3 Variations of factor XII level during pregnancy in a woman with Hageman factor deficiency.
JF Schved, JC Gris, S Neveu, P Mares, C Sarlat.
Thrombosis and Haemostasis 1988, 60: 526-527.
4 Factor XII congenital deficiency and early spontaneous abortion.
JF Schved, JC Gris, S Neveu, D Dupaigne, P Mares.
Fertility and Sterility 1989, 52: 335-336.
5 Myelodysplastic syndrome and secondary acute leukemia after treatment of essential thrombocytemia with melphalan.
JC Gris, JF Schved, A Arnaud, C Chauvet.
American Journal of Haematology 1989, 30: 47 (Letter)
6 Pathogenesis of Crohn’s disease.
JF Schved, JC Gris, A Dubois, C Raffanel, P Aguilar-Martinez.
Lancet 1989, ii: 1460 (Letter).
7 Pneumocystis carinii infection of the bone marrow in patients with malignant lymphoma and acquired immunodeficiency syndrome (AIDS).
JF Rossi, JJ Eledjam, A Delage, C Bengler, JF Schved.
Archives of Internal Medicine 1990, 150: 450-452.
8 Impaired fibrinolytic capacity in patients with inflammatory bowel disease.
JC Gris, JF Schved, C Raffanel, A Dubois, P Aguilar-Martinez, A Arnaud, N Sanchez, C Sarlat, JL Balmes.
Thrombosis and Haemostasis 1990, 63, 3: 472-475.
9 Impact of smoking, physical training and weight reduction on F VII, PAI1 and haemostatic markers in sedentary men.
JC Gris, JF Schved, O Feugeas, P Aguilar-Martinez, A Arnaud, C N Sanchez, C Sarlat.
Thrombosis and Haemostasis 1990, 64: 516-520.
10 Impaired fibrinolytic capacity and early recurrent spontaneous abortion in young women.
JC Gris, JF Schved, S Neveu, C Courtieu, D Dupaigne. P Martinez, P Mares.
British Medical Journal 1990, 300: 1500.
11 Impact of physical training on plasminogen activator inhibitor activity in sedentary men.
JC Gris, JF Schved, P Aguilar-Martinez, A Arnaud, N Sanchez.
Fibrinolysis 1990, 4, Supp 2:97-98.
12 Study of the quantitative modifications of plasma protein S components in non-acute inflammatory syndromes.
JF Schved, JC Gris, C Sarlat, J Amiral, S Brun, C Brunschwig, I Patris,
M Lassonery
Nouvelle Revue Françaised'Hématologie1990, 32: 271-276.
13 The initial release of t-PA induced by DDAVP is more important with low molecular weight heparin than with unfractionated heparin.
JF Schved, JC Gris, C Sarlat.
Thrombosis and Haemostasis 1991, 65: 109 (Letter).
14 Venous occlusion and chronic cigarette smoking: dose dependent decrease in the measurable release of tissue-type plasminogen activator and of von Willebrand factor.
JC Gris, JF Schved, S Brun, C Brunschwig, I Petris, M Lassonery, P Martinez, C Sarlat.
Atherosclerosis1991, 91: 247-255.
15 Prognostic relevance of von Willebrand factor antigen, tissue-type plasminogen activator plasma levels in HIV related clinical disease.
JF Schved, JC Gris, A Arnaud, P Martinez, JL Wautier, C Sarlat.
Journal of Laboratory and Clinical Medicine 1992, 120: 411-419.
16 Procoagulant activityof endotoxin or tumour necrosis factor activated monocytes is enhanced by IgG from patients with lupus anticoagulant.
JF Schved, JC Gris, V Ollivier, JL Wautier, G Tobelem, J Caen.
American Journal of Hematology1992, 120: 411-419.
17 Study of the protein S system in HIV-infected patients: acquired protein S deficiency or unsuitable assays?
JF Schved, JC Gris JC, A Michaud, J Amiral, D Quincat, A Arnaud,
P Martinez.
Blood Coagulation and Fibrinolysis 1992, 3:295-301.
18 Potential coexistence of haemophilia A and B carrier status in two sisters.
P Martinez, R Navarro, JF Schved, JC Gris, H Bonnet, J Demaille.
Prenata lDiagnosis 1992, 11: 972-973
19 A Plasma antifibrinopeptide A autoantibody in a patient with a severe acquired hemorrhagic syndrome.
JC Gris, JF Schved, B Branger, P Aguilar-Martinez, F Vecina, R Oulès,
C Sarlat, J Fourcade.
Blood Coagulation and Fibrinolysis 1992, 3: 519-529.
20 Meningococcemia in an adult with hereditary C4b-binding protein deficiency: study of the variations of the protein S system.
JC Gris, JF Schved, P Martinez, C Bengler, F Lemesle, C Arich, C Sarlat.
Blood Coagulation and Fibrinolysis 1992, 3: 673-677.
21 Immunohistochemical study of tumor cell-associated plasminogen activators and plasminogen activator inhibitors in lung carcinomas.
JC Gris, JF Schved, C Marty-Double, P Balmes.
Chest 1993, 104: 8-13
22 Familial association of high levels of histidine-rich glycoprotein and plasminogen activator inhibitor-1 with venous thromboembolism.
E Angles-Cano, JC Gris, S Loyau, JF Schved.
Journal of Laboratory and Clinical Medicine 1993, 121: 646-653
P Aguilar-Martinez, F Galacteros, JF Schved, Y Blouquit, JC Gris,
J Demaille, M Claustres.
Annals of Hematology1993, 66: 269-272
24 Rapid recovery of acquired purpura fulminans in a patient with familial C4bBP deficiency.
FG Lemesle, JC Gris, JF Schved, C Arich.
Intensive Care Medicine 1993; 19: 115-116.
25 Hypoxia inhibits tissue-plasminogen activator production in cultured human endothelial cells. Role of oxygen radicals.
O Palluy, JC Gris, JF Schved, L Merklein, C Bonne, G Modat
Endothelium 1993, 1: 173-178
JC Gris, S Neveu, P Mares, B Hedon, JF Schved.
Journal of Laboratory and Clinical Medicine 1993, 122: 606-615
27 Direct carrier testing of haemophilia B by SSCP.
PA Martinez, MC Romey, JF Schved, JC Gris, J Demaille.
Clinic and Laboratory in Haematology 1993; 16: 15-20
28 Tissue-type plasminogen activator level is decreased in human seminal plasma with abnormal liquefaction.
A Arnaud, JF Schved, JC Gris, P Costa, H Navratil, C Humeau.
Fertility Sterility 1994, 61: 741-745
29 Effects of an anti-interleukin-6 (IL-6) murine monoclonal antibody in a patient with acute monoblastic leukemia.
R Bataille, XG Zhang, J Wijdenes, JF Schved, B Klein.
Medical Oncology and Pharmacotherapy 1993, 10, 4: 87-94
30 DNA analysis of haemophilia A families from southern France. Experience of a hospital laboratory.
P Aguilar-Martinez, N Fabre, R Navarro, JF Schved, JC Gris,
MC Romey, J Demaille, M Claustres.
Genetic Counselling 1993, 4, 4: 311-319
31 A novel mutation (Val-373 to Glu) in the catalytic domain of factor IX, resulting in moderately/severe hemophilia B in a southern French patient.
P Aguilar-Martinez, MC Romey, JC Gris, JF Schved, J Demaille, M Claustres
Human Mutation 1994; 3: 156-158
32 Factor IX gene mutations causing haemophilia B: comparison of SSC screening versus systematic DNA sequencing and diagnostic applications.
P Aguilar-Martinez, MC Romey, JF Schved, JC Gris, J Demaille,
M Claustres.
Human Genetics 1994; 94: 287-290
33 Increased cardiovascular risk factors and features of endothelial activation and dysfunction in dialyzed uremic patients.
JC Gris, B Branger, F Vecina, Basabadani, J Fourcade, JF Schved
Kidney International 1994, 46: 807-813
34 Increased plasmin generation and activity in HIV-infected patients: in vivo rather than in-vitro activation of the fibrinolytic system.
P Toulon, JC Gris, N Candia, Y Demay, D Sereni, D Sicard, JF Schved
Fibrinolysis 1994, 8, S2: 132-134
35 A prospective epidemiological study on the occurrence of antiphospholipid antibodies: the Montpellier antiphospholipid (MAP) study.
JF Schved, C Dupuy-Fons, C Biron, I Quéré, C Janbon
Haemostasis 1994, 24: 175-182
36 Use of a low molecular weight heparin (enoxaparin) or of a phenformin-like substance ( moroxydine) chloride) in primary early recurrent abortion with an impaired fibrinolytic activity capacity.
JC Gris, S Neveu, ML Tailland, C Courtieu, P Mares, JF Schved.
Thrombosis and Haemostasis 1995, 73: 362-367
37 Anticardiolipin antibodies and acute alcoholic intoxication.
C Biron, N Lalloyer, JL Tonnelot, D Larget, JC Gris, JF Schved.
Lupus 1995, 4: 486-490
38 The Montpellier antiphospholipid antibodies (MAP) study: prevalence and clinical significance of antiphospholipid antibodies in an internal medicine department.
C Biron, C Dupuy-Fons, I Quéré, PA Martinez, C Janbon, JF Schved.
Nouvelle Revue Française d'Hématologie 1995, 37, S2: s73-s77
39 Antiphospholipid antibodies in HIV-infected patients are not associated with aprothrombotic state.
P Toulon, JC Gris, D Salmon, N Candia, D Sereni, D Sicard, JF Schved.
Nouvelle Revue Française d'Hématologie 1995, 37, S2: s97-s101
40 Direct carrier detection for severe haemophilia A : an application to families with no available affected males
C Maugard, P Aguilar-Martinez, JF Schved, C Biron, JC Gris, J Demaille,
M Claustres.
Genetic Counselling 1995, 6, 2: 109-112
41 Activation of coagulation and fibrinolysis in HIV-infected patients.
P Toulon, JC Gris, D Salmon, N Candia, D Sereni, D Sicard, JF Schved.
Fibrinolysis 1996; 10 S2: 1-3
42 The relationship between plasma microparticles, protein S and anticardiolipin antibodies in patients with human immunodeficiency virus infection.
JC Gris, P Toulon, S Brun, C Maugard, C Sarlat, JF Schved, J Berlan.
Thrombosis Haemostasis 1996; 76: 38-45
43 Antiphospholipid antibodies in patients with chronic hepatitis C virus infection or alcoholic liver disease. Preliminary results.
C Biron, H Andréani, P Blanc, J Ducos, D Larrey, H Michel, JF Schved.
Annales de Médecine Interne 1996, 147: 48-49
44 A novel mutation in the iron responsive element of ferritin L-subunit gene as a cause for hereditary hyperferritinemia-cataract syndrome.
P Martinez, C Biron, C Masmejean, P Jeanjean, JF Schved.
Blood 1996, 88, 5:1895
45 Hemostasis parameters during ovarian stimulation for in-vitro fertilization: results of a prospective study.
C Biron, F Galtier-Dereure, H Rabesandratana, I Bernard,
P Aguilar-Martinez, JF Schved, B Hedon.
Fertility Sterility 1997, 67, 1: 104-109
46 RPCA diagnosis strategy in APC resistance : is genotyping still necessary?
C Biron, H Lamarti, JF Schved, P Jeanjean, C Masmejean, M Claustres,
P Aguilar-Martinez.
Laboratory in Clinical Hematology 1997, 19 : 67-71
47 Protein truncation test: detection of severe haemophilia mutation and analysis of factor VIII transcripts.
C Maugard, S Tuffery, P Aguilar-Martinez, JF Schved, JC Gris, S Claeyssens, J Demaille, M Claustres.
Human Mutation 1998, 11: 18-22
48 Acquired isolated factor VII deficiency during sepsis.
C Biron, C Bengler, JC Gris, JF Schved
Haemostasis 1997, 27, 51-56
49 Simple and rapid detection of the newly describes mutations in the HLA-H gene.
P Aguilar-Martinez, P Jeanjean, C Masmejean, A Guillard, C Biron,
H Rabesandratana, JF Schved.
Blood 1997, 89, 5: 1835-1836
50 Compound heterozygotes for hemochromatosis gene mutations : may they help to understand the pathophysiology of the disease?
P Aguilar-Martinez, C Biron, F Blanc, C Masmejean, P Jeanjean, H Michel, JF Schved.
Blood Cells, Molecules and Disease 1997, 23, 13: 269-376
51 Prevalence of antiphospholipid antibodies in patients with chronic liver disease related to alcohol or hepatitis C virus: correlation with liver injury.
C Biron, H Andréani, P Blanc, J Ramos, J Ducos, N Guigue,
H Michel, D Larrey, JF Schved.
Journal of Laboratory and Clinical Medicine 1998; 131: 243-50
52 Vascular complications of diabetes mellitus: what role for phospholipid-binding antibodies?
F Galtier-Dereure, C Biron, M Vies, V Bourgeois, JF Schved,
J Bringer.
Lupus 1998, 7: 469 - 474
53 Association of red-blood methylfolate but not plasma folate with C677T MTHFR polymorphism in venous thromboembolic disease.
I Quéré, R Wurtschert, J Zittoun, H Bellet, G Reber, JC Gris, C Janbon,
JF Schved, P de Moerloose
Thrombosis Haemostasis 1998; 80: 707-709
54 An even easier method for one step detection of both FV Leiden and FII G20210A transition
M Giansily, C Biron, PJeanjean, CMasmejean, JFSchved,
P Aguilar Martinez
Blood 1998; 80: 3478-3479
55 Preoperative screening for von Willebrand disease type 1: low yield and limited ability to predict bleeding.
C Biron-Andréani, B Mahieu, A Rochette, X Capdevilla, A Castex, J Amiral,
F D’Athis, JF Schved.
Journal of Laboratory and Clinical Medicine, 1999; 134: 605-609
56 Haplotype analysis of the HFE gene: implications for the origins of hemochromatosis related mutations.
P Martinez, C Thelcide, P Jeanjean, C Masmejean, M Giansily, JF Schved.
Blood Cells, Molecules, and Diseases 1999, 25: 166-169
57 Oral anticoagulant drugs: do not cut tablets in quarters.
C Biron, P Licznar, S Hansel, JF Schved.
Thrombosis Haemostasis 1999; 82: 1201
58 Plastic versus siliconized glass tubes: evaluation in current laboratory practice.
C Biron-Andréani, C Mallol, F Séguret, JF Schved.
Thrombosis Haemostasis 2000; 83: 800-801
59 A new dilution for the modified APTT-based assay for activated protein C resistance: improvement of the reliability in patients with a lupus anticoagulant.
N Benattar, JF Schved, C Biron-Andréani.
Thrombosis Haemostasis 2000; 83: 967-968
60 Comparison of thrombotic risk between 85 homozygotes and 481 heterozygotes carriers of the factor V Leiden mutation : retrospective analysis from the procure study.
C Biron-Andréani and the Procare Group
Blood Coagulation and Fibrinolysis 2000; 11: 511-518
61 Iron overload in thalassemias and genetic haemochromatosis
P Aguilar-Martinez, JF Schved, C Badens, I Thuret, G Michel, MG Neonato, JY Peltier, R Girot, S Pissard, F Galacteros, D Bachir, C Rose, MC Picot,
E Denamur, J Elion
European Journal of Haematology 2000; 64: 279-280
62 Antiphospholipid antibodies in alcoholic liver disease are influenced by histological damage but not by alcoholic consumption.
P Perney, C Biron-Andréani, E Jommaye, P Fabbro-Perray, F Quenet,
JF Schved, F Blanc.
Lupus 2000; 9 : 451-455
63 Denaturation gradient gel electrophoresis screening for mutations in the hereditary hyperferritinemia cataract syndrome.
M Giansily, C Beaumont, C Desveaux, G Hetet, JF Schved,
P Aguilar-Martinez.
British Journal of Haematology 2001; 112: 51-54
64 Prenatal diagnosis of severe factor VII deficiency using mutation detection and linkage analysis.
M Giansily-Blaizot, P Aguilar-Martinez, C Mazurier, F Cneude,
J Goudemand, JF Schved, B de Martinville.
British Journal of Haematology 2001; 112: 251-252
65 Analysis of the genotypes and phenotypes of 34 unrelated patients with inherited factor VII deficiency
M Giansily, P Aguilar-Martinez, C Biron-Andréani, P Jeanjean, H Igual,
JF Schved.
European Journal of Human Genetics 2001; 9: 105-112
66 Variable phenotypic presentation of iron overload in H63D homozygotes : are gene modifiers the cause?
P Aguilar-Martinez, M Bismuth, MC Picot, C Thelcide, GP Pageaux, F Blanc, P Blanc, JF Schved, D Larrey.
Gut 2001, 48: 836-842
67 Transferrin receptor-2 gene and non-C282Y homozygous patients with hemochromatosis.
P Aguilar-Martinez, C Escudie-Coste, M Bismuth, M Giansily-Blaizot,
D Larrey, JF Schved.
Blood Cells, Molecules and Diseases 2001; 27: 290-293
68 Successful use of recombinant factor VIIa in a Haemophiliac with inhibitor undergoing cataract surgery
C Biron-Andreani, G Dupeyron, M Mainemer, JF Schved
Blood Coagulation and Fibrinolysis 2001, 12:1-2
69 Preanalytical recommendations of the “Groupe d’Etude sur l’Hémostase et la Thrombose” (GEHT) for venous blood testing in hemostasis laboratories.
B Polack, JF Schved, B Boneu on behalf of the “Grouped’Etudesurl’Hémostase et la Thrombose”( GEHT)”
Haemostasis 2001; 31: 61-68
70 Acquired haemophilia in the elderly is a severe disease: report of five new cases.
S Godreuil, R Navarro, P Quittet, L Landreau, JF Schved, C Biron-Andréani.
Haemophilia 2001; 7: 428-32
71 Prevalence of HFE mutations in people from North Africa living in Southern France.
P Aguilar-Martinez, M-C Picot, F Becker, P Boulot, F Montoya, P Mares,
B Bachelard, Y Henry, J Delarbre, P Sarda, P Jeanjean, H Igual, JF Schved.
British Journal of Haematology 2001; 114: 1-4
72 Venous thromboembolism during preganancy: a retrospective study of enoxaparin safety in 624 pregnancies.
L Lepercq, J Conard, A Boerl-Derlon, JY Darmon, O Boudignat,
C Francoual, P Priollet, C Cohen, N Yvelin, JF Schved, M Tournaire,
JY Borg.
British Journal of Obstetrics and Gynaecology 2001; 108: 1134-1140
73 Genotypic heterogeneity may explain phenotypic variations in inherited factor VII deficiency.
M Giansily-Blaizot, P Aguilar-Martinez, JF Schved.
Haematologica 2001; 87: 286 - 287
74 Red blood cell methylfolate and plasma homocysteine as risk factors for venous thromboembolism: a matched case-control study.
I Quéré, TV Pernegger, J Zittoun, H Bellet, JC Gris, JP Daurès, JF Schved,
E Mercier, JP Laroche, M Dauzat, H Bounameaux, C Janbon,
Ph de Moerloose.
The Lancet 2002, 359: 747-752
75 Inherited factor VII deficiency and surgery: clinical data are the best criteria to predict the risk of bleeding.
M Giansily-Blaizot, C Biron-Andreani , P Aguilar-Martinez,P de Moerloose,
M-E Briquel, J Goudemand, N Stieltjes, C Barrot, H Chambost, V Gay,
J Peynet, K Pouymayou, J-F Schved
British Journal of Haematology 2002; 117: 172-175
76 Model of ternary complex between activated factor VII, tissue factor and factor IX.
WC Shu-Wen, JL Pellequer, JF Schved, M Giansily-Blaizot.
Thrombosis Haemostasis 2002; 88: 74-82
77 The thrombogram in rare inherited coagulation disorders: its relation to clinical bleeding.
R Al Dieri, F Peyvandi, E Santagostino, M Giansily, PM Mannucci,
JF Schved, S Beguin, HC Hemker.
Thrombosis Haemostasis 2002; 88: 576 - 582
78 Thrombosis and antiphospholipid antibodies in non-SLE patients: predictive value of antiphosphatidylserine antibodies.
C Biron-Andréani, C Mallol, C Vergnes, N Benattar, JF Schved.
Pathophysiology of Haemostasis and Thrombosis 2002; 32:194.
79 Acute hepatitis C virus infection detected in a blood donor by nucleic acid testing.
J Coste, T Levayer, J Izopet, S Laperche, P Parneix, H Rech, JL Payen,
JF Schved.
Transfusion 2003; 43: 116-118
80 Two novel cases of cerebral haemorrhages at the neonatal period associated with inherited factor VII deficiency, one of them revealing new nonsense mutation (SER52STOP)
M Giansily-Blaizot, P Aguilar-Martinez, ME Briquel, R D’Oiron,
E De Maistre, S Epelbaum, JF Schved.
Blood Coagulation Fibrinolysis 2003; 14: 217-220
81 Thrombosis in inherited factor VII deficiency.
G Mariani, FH Hermann, S Schulman, A Batorova, K Wulf, D Etro, A Dolce, G Auerswald, J Astermark, JF Schved, J Ingerslev, and F Bernardi for the International factor VII deficiency study group.
Journal of Thrombosis and Haemostasis 2003; 1: 2153-2158
82 Amniotic fluid embolism with haemostasis complications: primary fibrinogenolysis or disseminated intravascular coagulation?
C Biron-Andréani, E Moreau, JF Schved, B Hédon, H Dechaud
Pathophysiology of Haemostasis and Thrombosis 2003; 33: 170-171
83 Thrombin generation measurement in factor VII-depleted plasmas compared to inherited factor VII-deficient plasmas.
M Giansily-Blaizot, R Al Dieri, JF Schved.
Pathophysiology of Haemostasis and Thrombosis 2003; 33: 36-42
84 Suggestions for an appropriate methodological approach for the validation of an evacuated blood collection tube made in plastic material including the effect of age.
K Foucher, P Toulon, JF Schved, B Polack.
Thrombosis Haemostasis 2004; 91: 845-847
85 Use of serial analysis of gene expression (SAGE) technology reveals new granulocytic markers.
G Bertrand, J Coste, C Segarra, JF Schved, T Commes, J Marti.
Journal of Immunology Methods 2004; 292: 43-58
86 Secretion of functional plasma haemostasis protein in long term plenary cultures of human hepatocytes.
C Biron-Andréani, C Bezat-Bouchada, E Raulet, L Pichard-Gracia,
JM Fabre, J Saric, J Baulieux, JF Schved, P Maurel
British Journal of Haematology 2004; 125: 638-646
87 Analysis of biological phenotypes from 42 patients with inherited Factor VII deficiency: can biological tests predict the bleeding risk?
M Giansily-Blaizot, R Verdier, C Biron –Andréani, JF Schved Haematologica 2004; 89: 704-709
88 Perioperative platelet transfusion : recommendations of the Agence Française de sécurité sanitaire des produits de santé
CM Samama, R Djoudi, T Lecompte, N Nathan-Denizot, JF Schved
and the AFSSaPS Expert Group
Canadian Journal of Anesthesia 2005; 52: 30-37
89 The evaluation of hyperferritinemia: an updated strategy based on advances in detecting genetic abnormalities
P Aguilar-Martinez, JF Schved, P Brissot.
American Journal of Gastroenterology 2005; 100: 1-10
90Immunonephelemetric determination of fibrinogen on citrated or heparinized plasma: comparison with functional Clauss method
AS Bargnoux, AM Dupuy, C Biron-Andréani, JF Schved, JP Cristol
Clinical Laboratory 2005; 51: 285-288
91 Anti Factor VIII antibodies. A 2005 update
G Lavigne-Lissalde, JF Schved, C Granier, S Villard
Thrombosis Haemostasis 2005; 94: 760-769
92 Potential predictors of bleeding risk in inherited factor VII deficiency. Clinical, biological and molecular criteria
M Giansily-Blaizot & JF Schved
Thrombosis Haemostasis 2005; 94: 901-906
93Preoperative autologous blood donation: a therapy that needs to be scientifically evaluated
JF Schved
Transfusion Clinique et Biologique 2005; 12: 365-369
94 Clinical phenotypes and factor VII genotype in congenital factor VII deficiency
G Mariani, F Herrmann, A Dolce, A Batorova, D Etro, F Peyvandi, K Wulff, JF Schved, G Auerswald, J Ingerslev, F Bernardi for the International Factor VII Deficiency Group
Thrombosis Haemostasis 2005; 93: 481-487
95 Guidelines of the French Society for Digestive endoscopy (SFED)
B Napoleon, B Boneu, L Maillard, CM Samama, JF Schved, G Gay,
T Ponchon, D Sautereau, JM Canard
Endoscopy 2006; 6: 632-638
96 Functional regulatory T cells are collected in stem cell autografts by mobilization with high-dose cyclophosphamide and granulocyte colony-stimulating factor
M Condomines, P Quittet, L Zy, L Nadal, P Latry, E Lopez, M Baudard, G Requirand, C Duperray, JF Schved, JF Rossi, K Tarte, B Klein
Journal of Immunology 2006; 176: 6631-6639
97 Factor V Leiden mutation and pregnancy-related venous thromboembolism: what is the exact risk? Results from a meta-analysis
C Biron-Andreani, JF Schved, JP Daurès
Thrombosis Haemostasis 2006; 96: 14-18
98Accurate characterization of the IVS7 repeat polymorphism of FVII gene and identification of three novel allelic forms
M Giansily-Blaizot, L Flory-Pigagniol, R Favier, RA Farah, I Martin-Toutain, E Verdy, JF Schved
Thrombosis Haemostasis 2006; 95-97
99 Rapid detection of beta-Thalassemia alleles in Egypt using naturally or amplified created restriction sites and direct sequencing: a step in disease control
G Hussein, M Fawzy, T El Serafi, EF Ismail, D El Metwally, MA Saber, M Giansily-Blaizot, JF Schved, S Pissard, P Aguilar-Martinez
Hemoglobin 2007; 31: 49-62
100 Cancer/testis genes in multiple myeloma: expression patterns and prognosis value determined by microarray analysis
M Condomines, HD Raynaud, M Hundemer, J De Vos, M Baudard,
T Moehler, V Pantesco, M Moos, JF Schved, JF Rossi, T Reme,
H Goldschmidt, B Klein
Journal of Immunology 2007; 178: 3307 – 3315
101 A novel mutation of the beta-globin gene promoter (-102 C>A) and pitfalls in family screening.
P Aguilar-Martinez, E Jourdan, S Brun, S Cunat, M Giansily-Blaizot,
S Pissard, JF Schved
American Journal of Hematology 2007; 82: 1088-1090
102 Molecular characterization of human B domain-specific anti-factor VIII monoclonal antibodies generated in transgenic mice.
G Lavigne-Lissalde, S Lacroix-Desmazes, B Woothla, C Tarrade, JF Schved, S Kaveri, C Granier, S Villard
Thrombosis Haemostasis 2007; 98: 138-147
103 Characterisation of a large complex intragenic re-arrangement in the FVII gene (F7) avoiding misdiagnosis in inherited factor VII deficiency.
M Giansily-Blaizot, D Thorel, P Khau Van Khien, C Behar, MC Romey,
F Mugneret, JF Schved, M Claustres
British Journal of Haematology, 2007; 138: 359-365
104 Global sequencing approach for characterizing the molecular background of hereditary iron disorders.
S Cunat, M Giansily-Blaizot, M Bismuth, F Blanc, O Dereure, D Larrey,
A Le Quellec, P Pouderoux, C Rose, I Raingeard, E Renard, JF Schved,
P Aguilar-Martinez; CHU Montpellier AOI 2004 Working Group.
Clinical Chemistry 2007; 53: 12; 2060-2069
Menu
Jean François Schved Écrivain Hématologue Professeur au CHU Montpellier
Schved Écrivain Hématologie CHU Montpellier Plongées Voyage Harmattan Glyphe Hématologue